Tactic Gem Llc Monopar Therapeutics (MNPR) insider trading activity
Tactic Gem LLC is > 10% Shareholder of Monopar Therapeutics. Currently has a direct ownership of 0 shares of MNPR, which is worth approximately $0. The most recent transaction as insider was on Dec 09, 2024, when has been sold 1,433,334 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
0
n/a
3M change
n/a
12M change
Total Value Held
$0
TL
Tactic Gem LLC
> 10% Shareholder
Lake Forest, IL